Product
GSK1795091
1 clinical trial
1 indication
Indication
CancerClinical trial
A Phase I, Open-Label Study of GSK1795091 Administered in Combination With Immunotherapies in Participants With Advanced Solid TumorsStatus: Completed, Estimated PCD: 2020-07-01